Skip to main content
Hit enter to search or ESC to close
Close Search
ADx Neurosciences - State-of-the-art biomarker assaysADx Neurosciences - State-of-the-art biomarker assays
search
Menu
  • Home
  • Pharma Solutions
  • IVD Solutions
  • Portfolio
  • About Us
    • Board of directors
    • Management team
  • News and Media
  • Contact
  • search
Category

Tau

Categories

  • Synapses
  • Synuclein
  • Tau
  • Amyloid
  • News
  • Publications
  • Events

Recent Posts

  • ADx will be present at the upcoming virtual AAIC 2020
  • ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.
  • Present at CTAD 2019
  • ADx receives funding from Bill Gates for developing blood biomarkers
  • Cancellation ADx Neuro Biomarker Conference

Archives

  • January 2021
  • August 2020
  • July 2020
  • April 2020
  • December 2019
  • November 2018

    Subscribe to newsletter

    Subscribe to get notified about ADx breakthroughs. You could unsubscribe at any time.

    Our Company

    ADx NeuroSciences NV
    Technologiepark 94
    9052 Gent

    BTW: 0839.400.980

    Navigation

    • Home
    • Pharma Solutions
    • IVD Solutions
    • Portfolio
    • About Us
    • News and Media
    • Contact

    Information

    • Privacy Statement
    • Cookie policy
    • Exercise form
    • General Terms & Conditions of Sale

    Credits

    Website by Turnstone

    Close Menu
    • Home
    • Pharma Solutions
    • IVD Solutions
    • Portfolio
    • About Us
      • Board of directors
      • Management team
    • News and Media
    • Contact